Clinical Trials Browser

Recruiting × Observational × darolutamide × Clear all

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT06661122 2026-05-19

HAYATE

Recruiting

100 enrolled

Genitourinary

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT06334120 2026-05-13

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

Recruiting

600 enrolled

Genitourinary

Non-metastatic Castration-resistant Prostate Cancer

NCT07181122 2026-04-28

PRO-MIND

Recruiting

102 enrolled

Genitourinary

Depression, Fatigue, Sleep Initiation and Maintenance Disorders, Prostatic Neoplasms

NCT07406282 2026-04-09

Double-DARE

Recruiting

1,400 enrolled

Genitourinary

Prostatic Neoplasms

NCT06724159 2026-02-17

SOGUG-PRINCIS

Recruiting

500 enrolled

Genitourinary

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urogenital Neoplasms

NCT06652607 2025-03-12

PSA-DEEP02

Recruiting

152 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT06473259 2024-06-25

ECHOS

Recruiting

3,000 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Clinical Trials

23146

HAYATE

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

PRO-MIND

Double-DARE

SOGUG-PRINCIS

PSA-DEEP02

ECHOS